c-myc promotes survival of WEHI 231 B lymphoma cells from apoptosis.
Wu
M
M
Department of Biochemistry, Boston University School of Medicine, MA 02118, USA.
Yang
W
W
Bellas
R E
RE
Schauer
S L
SL
FitzGerald
M J
MJ
Lee
H
H
Sonenshein
G E
GE
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D023201:CD40 Ligand; D016259:Genes, myc / Q000187:drug effects; D007075:Immunoglobulin M / Q000378:metabolism; D016393:Lymphoma, B-Cell / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D008562:Membrane Glycoproteins / Q000494:pharmacology; D051379:Mice; D016328:NF-kappa B / Q000037:antagonists & inhibitors; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D007075:Immunoglobulin M; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016212:Transforming Growth Factor beta; D023201:CD40 Ligand; D014108:Tosylphenylalanyl Chloromethyl Ketone